Mizuno Y, Gotoh A, Kamidono S, Kitazawa S
Department of Urology, Kobe University School of Medicine.
Nihon Hinyokika Gakkai Zasshi. 1993 Jul;84(7):1211-8. doi: 10.5980/jpnjurol1989.84.1211.
A new human testicular cancer cell line (TCam-2) was established. The original material of TCam-2 was a primary lesion of a left testicular seminoma (typical pure type seminoma) from a 35 aged male patient. TCam-2 produced neither AFP nor beta-HCG, It showed strong immunoreactivities for 5G9 (anti testicular cancer MoAb), 4B3 (anti PTHrP MoAb) and PALP (placental alkaline phosphatase). The chromosomal analysis revealed 92 modal number and loss of Y chromosome. Histochemical, morphological and chromosomal analysis supported that TCam-2 is from classical seminoma. TCam-2 was transplanted subcutaneously to the back of 6 weeks old scid mice (CB-17 strain), and grew a classical seminomatous tissue.
建立了一种新的人睾丸癌细胞系(TCam-2)。TCam-2的原始材料来自一名35岁男性患者左侧睾丸精原细胞瘤(典型的纯型精原细胞瘤)的原发性病变。TCam-2既不产生甲胎蛋白也不产生β-人绒毛膜促性腺激素,它对5G9(抗睾丸癌单克隆抗体)、4B3(抗甲状旁腺激素相关蛋白单克隆抗体)和胎盘碱性磷酸酶表现出强免疫反应性。染色体分析显示众数为92且Y染色体缺失。组织化学、形态学和染色体分析支持TCam-2源自经典型精原细胞瘤。将TCam-2皮下移植到6周龄的重症联合免疫缺陷小鼠(CB-17品系)背部,生长出典型的精原细胞瘤组织。